Marksans pharma products. 51 Crore) operating in Pharmaceuticals sector.

Marksans pharma products We are engaged in generic pharmaceutical formulations research, manufacturing and marketing with three state-of-the-art manufacturing facilities in India, the United Kingdom and the United States. is an Indian pharmaceutical company with a significant global presence. Marksans Pharma Sub: Press Release Marksans Pharma Limited’s wholly owned subsidiary in UK, Relonchem Limited receives Marketing Authorization for its products. 6% to ~USD 34. key Products/Revenue Segments include Pharmaceuticals, Export Incentives and Scrap for the year ending 31-Mar-2025. Teva's affiliate Watson Pharma Private Limited will continue to own and operate its other manufacturing site at Verna Industrial Estate, Verna Salcette, Goa, India. - Find the complete list and range of Pharma products of Marksans Pharma Ltd. Aug 31, 2024 · Note: Marksans Pharma operates primarily as a single reportable segment (Pharmaceuticals) according to the report. jfJ()MAJ~ Harshavardhan Panigrahi Company Secretary About Marksans Pharma Ltd Marksans Pharma Limited (www. 40. This acquired facility is spread across 47,597 square meters and has approvals to manufacture products from EU, Health Canada, and Japanese Health Authority. The company's core competencies lie in the research, manufacturing, and marketing of finished dosage pharmaceutical formulations, focusing on delivering quality products to meet the diverse needs of the pharmaceutical industry. Earlier this week, the company's fully owned UK subsidiary, Relonchem Limited, received authorisation from the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) to market Marksans Pharma Ltd. Select the NDC to see product information. Get all the Marksans Pharma breaking news updates, videos, photostories and more at Business Standard. Our continued focus on R&D investments has led to a robust pipeline of newly developed pipeline products. The UK drug regulator has approved Cetirizine Dihydrochloride 1 mg/ml Oral Solution, used to treat a range of seasonal and year-round allergies. Find a price of Metformin bulk offered by Marksans Pharma Oct 8, 2025 · Company profile for Marksans Pharma Limited (NSE:MARKSANS) with a description, list of executives, contact details and other key facts. It supplies drugs such as antidiabetics, antibiotics, and others. Time-Cap possesses differentiated manufacturing capabilities with competitive advantages in extended and delayed-release products and specialized coating expertise Marksans Pharma Limited (BSE:524404), headquartered in Mumbai, India, manufactures and markets generic OTC pharmaceuticals globally and has a market cap of over $550 million An Indian pharmaceutical company having a global footprint Our strengths lie in research, manufacturing and marketing of finished dosage pharmaceutical formulations. The company's robust product portfolio Oct 2, 2020 · Manufacturer of Generic Pharmaceutical products. The company offers products in the pain management, cardiovascular, central nervous system, anti-diabetic, gastrointestinal, analgesics Indian Pharmaceutical Company who are into Pharmaceutical Drug Formulation manufacturing, Development and marketing of finished dosage. and its wholly owned subsidiary Marksans Pharma (UK) Ltd that includes 2 step-down subsidiaries: Bell, Sons & Co. NS) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investments 5 days ago · Marksans Pharma Limited, headquartered at Mumbai, India, is engaged in research, manufacturing & marketing of generic pharmaceutical formulation in the global markets. Find out about his known public assets. Marksans Pharma is an Indian pharmaceutical company specialising in over-the-counter (OTC) and prescription drugs. Our commitment to advancing healthcare extends to addressing the concerns surrounding hair loss. Marksans Pharma is engaged in the Business of Formulation of pharmaceutical products [1] The CNS, encompassing the brain and spinal cord, is a paramount domain in medical research and treatment. The strategic approach of Marksans centres on the integration and utilization of company strengths to propel growth. UK New Zealand Marksans Pharma entered strategic tie-ups and acquired key players in major markets to expand its global footprint Company can generate higher margins by eliminating third parties from the value chain Currently, the company markets products in 25+ countries with the UK and the US being the largest In keeping with Marksans Pharma’s vision to successfully cater to the diverse needs of global healthcare at affordable rates, the company acquired a manufacturing facility from Tevapharm, India. History Relonchem Ltd has been established in 2002 and is now a wholly owned subsidiary of Marksans Pharma Ltd, One of the large pharmaceutical manufacturers based in Mumbai, India with interests in the UK, Germany, USA, Canada and Australia. The facility’s scalable production Marksans Pharma Limited (www. company Marksans Pharma- Snapshot India’s leading pharmaceutical company with a focus on regulated markets, specializing in research, manufacturing and marketing of generic pharmaceutical formulations Since 2007, Marksans has been actively serving the UK market, establishing itself as one of the top Indian companies in the region. Background Marksans Pharma Limited (“Marksans” or “the Company”) promoted by Mr. At Marksans Pharma Ltd, we are dedicated to developing innovative solutions that provide relief and improve the quality of life for those affected by allergies. Nova Pharmaceuticals is one of the fastest growing pharmaceutical companies within the OTC category in Australia. Al, Phase l-A, Verna Industrial Estate, Verna, Goa Marksans Pharma is a manufacturer and distributor of pharmaceutical products. , Discover Mark Bosco Saldanha's known position history, network and 31 relationships. The acquisition was first announced in October 2022. On the call today representing Marksans Pharma, we have Mr. In August 2008, Marksans acquired Relonchem Ltd. The supplier company is located in Verna, Goa and is one of the leading sellers of listed products. 22% to Rs 207. Marksans Pharma Limited - VRIO Analysis: Brand Value Value: Marksans Pharma’s brand value is crucial in establishing customer trust and loyalty. Buy Allophatic medicine, vitamin b complex, dry syrups in bulk from us for the best quality products and service. Our primary expertise lies in proactively addressing and meeting the rising demands of our clients, positioning us as the preferred business partner. , along with our two step-down subsidiaries, Bell, Sons & Co. Our presence is facilitated through Marksans Pharma UK Ltd. 35 after the company announced that its Goa-based manufacturing facility has been approved by Australian TGA for manufacture of pharmaceutical formulations for Australian markets. The company's manufacturing facilities are approved by several leading regulatory agencies including USFDA, UKMHRA and Australian 6 days ago · See the latest Marksans Pharma Ltd stock price (MARKSANS:XNSE), related news, valuation, dividends and more to help you make your investing decisions. Mark Saldanha is manufacturer of generic pharmaceuticals across regulated markets – soft gelatin capsules & tablets in niche segments Also undertakes Formulation CRAMS At Marksans, we have a clear vision to translate our ideas into reality – relying on a bedrock of innovation, distinct capabilities and a focused strategy to give direction to our thoughts. It is engaged in Research, Manufacturing & Marketing of generic pharmaceutical formulation in the global markets. The medication is used to relax certain muscles in the body, alleviating Jul 7, 2025 · Trade Spotlight: How should you trade Relaxo Footwears, Chennai Petroleum, Transrail Lighting, CCL Products, Marksans Pharma, Titan, and others on July 7? Consolidation is expected to continue in 4 days ago · Marksans Pharma’s UK subsidiary, Relonchem Limited, has received marketing authorisation from the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) for its anti-allergy medicine, the company said in an exchange filing on Thursday. In comparison, BSE Sensex was trading 0. The Company services this region through Marksasn Pharma Ltd. Jitendra Sharma – Chief Financial Officer. Presently, we have over 50 FDA-approved products, offering a broad range of more than 100 products under our Bells Healthcare brand in the UK and an extensive catalogue of over 160 products under our Relonchem brand. The Company's By adhering to this CSR policy, Marksans Pharma strives to make a positive and sustainable contribution to society, while ensuring the long-term success of our business. Intas serves sectors such as CNS, cardiovascular, diabetes, gastrointestinal, urology, oncology, and animal health. The Company services this region through Marksans Pharma Ltd and its wholly owned subsidiary Marksans Pharma (UK) Ltd that includes 2 step-down subsidiaries: Bell, Sons & C0. 0 billion by 2023, driven primarily by a universal coverage, growing disease burden and ease of healthcare access. Find the complete list of products marketed by Marksans Pharma Ltd. Apr 18, 2024 · Considering that Marksans Pharma derives approximately 74 percent of its sales from these products, this trend is expected to contribute to a robust margin profile for the drugmaker. 5 days ago · Marksans Pharma added that the Loperamide Hydrochloride tablet is an anti-diarrheal medication used to control symptoms of acute and chronic diarrhea. It is a leading supplier of branded generic and private-label products in Australia. Mark Saldanha – Founder, Chairman & Managing Director; and Mr. Our team of experts works tirelessly to bring you a diverse range of meticulously crafted products, catering to both water-soluble and fat-soluble vitamin requirements. marksanspharma. May 15, 2025 · Here's why Marksans Pharma share price increased over 2% in trade on May 15 At 11:20 PM, Marksans Pharma shares pared gains and were trading merely 0. 3) Major Strategic Initiatives and Their Progress # Acquisition of Tevapharm’s Goa Manufacturing Facility: Completed. It has a subsidiary Relonchem that received approval for Cyanocobalamin 50mg tablets from UK MHRA. Oct 11, 2022 · Drug firm Marksans Pharma on Tuesday said it has inked a pact with Tevapharm India to acquire its Goa-based bulk pharmaceutical formulations business. Time-Cap Labs offers OTC and Rx products for your private label available in bulk, bottles or blisters. Aug 14, 2024 · Shares of Marksans Pharma Ltd climbed 16 per cent in Wednesday's trade following the smallcap company's strong June quarter earnings and positive management commentary. For the third quarter, the company reported sales was INR 6,818. Our relentless efforts to explore new avenues of growth, accomplish cherished objectives and deliver unmatched performance empowers us to lay the foundation for consistent growth. 3 percent higher at Rs 50. * Oct 15, 2025 · Relonchem, a wholly-owned subsidiary of Marksans Pharma has received marketing authorization for two of its products from UK's Medicines and Healthcare products Regulatory Agency , according to a At Marksans Pharma Ltd, we recognize the profound impact that hair fall can have on individuals' well-being and confidence. (OTC portfolio) – acquired in 2008 Relonchem (High-end Rx portfolio) – acquired in 2008 These strategic acquisitions provided us with immediate sales & front-end access to the UK’s generic licensing market of Feb 22, 2022 · The UK pharmaceutical market is estimated to grow by a CAGR of 3. The company has entered into a business transfer agreement with Tevapharm to acquire its business relating to the manufacture and supply of bulk Indian Pharmaceutical Company who are into Pharmaceutical Drug Formulation manufacturing, Development and marketing of finished dosage. has gained immense expertise in supplying & trading of Allophatic medicine, vitamin b complex, dry syrups etc. Select the Trade Name to see similar products. Mark Saldanha, MD, Marksans Pharma said, "The completion of the manufacturing capacity from Tevapharm India is a significant milestone to strengthen our position as a leading low-cost manufacturer and to provide high-quality products to meet the growing demands of our customers. At Marksans Pharma Ltd, we are dedicated to developing breakthrough medications that address neurological disorders, mental health conditions, and other challenges affecting the CNS. Smallcap Pharma co with strong growth potential | Marksans Pharma Fundamental Analysis Indian Pharmaceutical Company who are into Pharmaceutical Drug Formulation manufacturing, Development and marketing of finished dosage. Featuring the wide range of medicines marketed by Marksans Pharma Ltd, ensuring trust and reliability in every product. Marksans Pharma Limited is headquartered at Mumbai, India. At Marksans Pharma, we are committed to conducting our operations with integrity, transparency, and a deep sense of social responsibility. A very warm welcome to Marksans Pharma's Limited Q2 FY'26 Post Results Earning Call hosted by DAM Capital Advisors Limited. Feb 10, 1994 · The company offers products including generic drugs, oncology and parenteral products, as well as biosimilars and plasma-derived therapeutics. The company reported growth About Marksans Pharma Ltd Marksans Pharma Limited (www. From antihistamines to breakthrough immunotherapies, our Apr 19, 2023 · Marksans Pharma on Wednesday said that it has completed the acquisition of a manufacturing site from Tevapharm India in Verna, Goa. , incorporated in the year 1992, is a Small Cap company (having a market cap of Rs 8,688. Jul 7, 2025 · Stocks to buy today: CCL Products (India) has shown renewed growth in the last couple of weeks, while Marksans Pharma has experienced a gradual resurgence over the last couple of trading sessions Apr 19, 2023 · Marksans Pharma completes the acquisition from Tevapharm India, expanding the existing manufacturing capacity in India Mumbai, April 19, 2023- Marksans Pharma Ltd. (Druggists) Limited and Relonchem, both acquired in 2008. With these successful consolidation activities, Marksans has the potential to grow significantly due to a wider product portfolio, better market access, and comprehensive R&D Aug 18, 2025 · Marksans Pharma Limited announced that its wholly owned subsidiary Relonchem Limited in UK has received Marketing Authorization for the below-mentioned products from UK MHRA: Metformin Hydrochloride Nov 4, 2025 · Marksans Pharma Limited is an India-based company, which is primarily engaged in the business of research, manufacture, marketing and sale of pharmaceutical formulations. On the call today, we are representing Marksans Pharma Management, Mr. The company's manufacturing facilities located in India, USA and UK are approved by several leading regulatory agencies Jul 12, 2023 · Marksans Pharma, a consumer self-care products manufacturer, plans to launch the product immediately, it stated, while mentioning that it is committed to expanding the portfolio in OTC pain management. Are you looking for Marksans Pharma Limited financials? Visit Tofler for its net worth, ratios, profit and loss, competition, products, industry, and financial analysis. Hide deleted NDCs: Manufacturer of drugs and pharmaceuticals with an NDC labeler name of: MARKSANS PHARMA LIMITED. Marksans operates on a strategically distinct model to realize its vision of creating a respected, profitable and integrated global pharmaceutical company. This will enable us to deliver a range of healthcare pharmaceuticals that meet consumer needs. Good afternoon, everyone, and a very warm welcome to Marksans Pharma’s Q1 FY2024 post earnings call, hosted by DAM Capital Advisors Limited. I will handover call to the Marksans team to make some opening . The company's manufacturing facilities located in India, USA and UK are approved by several leading regulatory agencies including USFDA, UKMHRA and Australian TGA. Oct 2, 2020 · Manufacturer of Generic Pharmaceutical products. Marksans Pharma is an Indian company that produces and markets finished dosage pharmaceutical formulations worldwide. Manufactures a diverse range of pharmaceutical products, medical supplies, plastic bags, and toys, ensuring quality and compliance with industry standards. Our CSR initiatives are aligned with our core values and aim to contribute positively to the well-being of communities, the environment, and various stakeholders. For the fiscal year ended March 2023, the company reported total revenue of ₹1,247 crore, showcasing its ability to command premium pricing due to brand reputation. With the completion of the acquisition, Marksans will start operating at the acquired facility, the company said in a regulatory filing. Sathish Kumar is Managing Director of Marksans Pharma (UK) Ltd. The company's manufacturing facilities are approved by several leading regulatory agencies including USFDA, UKMHRA and Australian TGA. Feb 11, 2025 · Marksans Pharma Limited reported earnings results for the third quarter and nine months ended December 31, 2024. Revenue breakdown by therapeutic segment prior to FY24 is not provided. Our cutting-edge research and development efforts focus on creating advanced pharmaceuticals that target specific allergic reactions, offering effective and tailored treatments. Mark Saldanha – Founder, Chairman and Managing Director, and Mr. Strategic low-cost manufacturing, active product registrations and front-end distribution have played an instrumental role in helping Marksans expand its business across key international markets. The company undertakes no duty to update forward-looking statements except as required by applicable law. Formulating pharmaceutical solutions for better health Marksans Pharma is a globally-trusted, customer-centric pharmaceutical company with a strong presence in regulated markets. 4 days ago · Marksans Pharma’s UK arm Relonchem has got yet another Medicines and Healthcare products Regulatory Agency’s (MHRA) nod to market one of its anti-allergy medicines. Marksans prides itself on superior R&D capabilities. The company's mission encapsulates its commitment to innovation, quality, and patient-centricity. Mar 19, 2025 · Marksans Pharma Ltd shares gained on Tuesday after its wholly owned UK subsidiary, Relonchem Ltd, secured Marketing Authorisation from the Medicines and Healthcare Products Regulatory Agency (MHRA) for Baclofen 10 mg Tablets. USA ClassificationUSA Thank you. Our range of products is designed to address specific aspects of these conditions, providing relief while also supporting the body's natural defenses. Oct 8, 2025 · Company profile for Marksans Pharma Limited (NSE:MARKSANS) with a description, list of executives, contact details and other key facts. Shares of Marksans Pharma are currently trading 8. (NSE: MARKSANS; BSE:524404), one of the fastest-growing pharmaceutical companies in India, has completed the acquisition of a manufacturing site from Tevapharm India in Plot No. Indian Pharmaceutical Company who are into Pharmaceutical Drug Formulation manufacturing, Development and marketing of finished dosage. The Company's product portfolio spreads over major therapeutic Marksans Pharma Limited (MPL) Marksans straddles across key therapy areas and markets its products in both evolving and developed markets Indian Pharmaceutical Company who are into Pharmaceutical Drug Formulation manufacturing, Development and marketing of finished dosage. The drug is used for short-term relief of mild to 3 days ago · Marksans Pharma Ltd. 51 Crore) operating in Pharmaceuticals sector. Mr. Nov 17, 2025 · Marksans Pharma’s fully owned UK subsidiary, Relonchem Limited, has received authorisation from the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) to market Mefenamic Acid Film-Coated Tablets in 250 mg and 500 mg strengths. This facility is expected to double the Company’s existing Indian production capacity Oct 30, 2025 · Chief Executive Officer at Marksans Pharma Ltd. Viewers should do their own research and diligence before investing or acting on the information presented. We further plan to enhance our product portfolio with an addition of twelve to thirteen products every year. PRODUCT LIST EUROPE At Marksans, we believe in a global mindset and actively engage in fostering international collaborations. Established in 1998 ,India Marksans Pharma Ltd. 46 million compared to Aug 8, 2025 · Marksans Pharma Limited Announces US FDA approval for Famotidine Tablets USP, 10 mg and 20 mg Details : Famotidine is an H2 antagonist, it inhibits acid secretion by blocking the action of histamine on the parietal cells, ultimately reducing acid secretion into the stomach. & manages affairs of Bells & Sons (Druggists) Ltd and Relonchecm Ltd, both step down operating subsidiaries of Marksans Pharma (UK) Ltd. Marksans Pharma Limited, together with its subsidiaries, is engaged in the research, manufacture, and marketing of generic pharmaceutical formulations worldwide. Mark Saldanha is manufacturer of generic pharmaceuticals across regulated markets – soft gelatin capsules & tablets in niche segments Also undertakes Formulation CRAMS About Marksans Pharma Ltd Marksans Pharma Limited (www. 08 per cent higher at Rs 238 per share. Marksans Pharma Ltd. Marksans Pharma Marksans Pharma Limited, established in 2004, is a global pharmaceutical player focused on delivering high-quality products and services. Marksans Pharma Limited, India is voluntarily expanding its earlier initiated recall on June 05, 2020 to include an additional 76 unexpired lots of Metformin Hydrochloride Extended-Release Tablets Aug 12, 2025 · Get Marksans Pharma Ltd (MARK. Marksans Pharma is a supplier offers 1 products (APIs, Excipients or Intermediates). Marksans Pharma is India’s leading pharmaceutical company specializing in the research, manufacturing, and marketing of generic pharmaceutical formulations Q4 and FY24 Financial and Business Q4 and FY24 Business & Financial Highlights Mar 20, 2025 · Marksans Pharma added 2. He has done masters in pharmacy and has over 20 years of experience in Pharma industry working across Production, Planning and inventory Management, Formulation development, Regulatory Oct 31, 2025 · Marksans Pharma Limited, together with its subsidiaries, engages in the research, manufacturing, marketing, and sale of pharmaceutical formulations in the United States, North America, Europe, the United Kingdom, Australia, New Zealand, and internationally. 10 per cent lower at 81,247. Marksans will continue to supply Teva's affiliates for certain products until the end of FY23as part of the agreement, which can be extended further with mutual agreement. For the Thank you, Carol. He has done masters in pharmacy and has over 20 years of experience in Pharma industry working across Production, Planning and inventory Management, Formulation development, Regulatory Marksans Pharma is a manufacturer and distributor of pharmaceutical products. 08 level. Our 4 world-class and accredited manufacturing units along with 4 highly capable R&D centres have propelled us toward rapid growth and success. The company is engaged in licensing, marketing, and distribution of prescription generic pharmaceutical products to wholesalers, retailers, and hospitals in the UK. The company's product portfolio spreads over major Marksans Pharma Ltd is dedicated to providing innovative and effective solutions to alleviate the diverse symptoms associated with cough and cold. com) headquartered at Mumbai, India is engaged in Research, Manufacturing & Marketing of generic pharmaceutical formulation in the global markets. Nova is engaged in the R&D and marketing of generic OTC products, with a focus on analgesics, antihistamines, anti-fungal, anti-allergy, dermatology, essential oils, and gastrointestinal segments 29 Vitamins Soft Gel Capsules Decavitamin Vitahom Vitamins VitaminsIraq The company offers its products to large and small wholesalers and distributors. As a part of the agreement, Marksans will continue to supply existing About Marksans Pharma Ltd Marksans Pharma Limited (www. 5 days ago · Products with assigned NDCs are displayed. We specialise in developing and manufacturing & distributing both over-the-counter (OTC) and prescription (Rx) drugs, aligning our oferings with the evolving needs of patients and healthcare providers across the world. Our undeterred focus on Quality Control (QC Aug 18, 2025 · Marksans Pharma - Read all the latest news headline updates on Marksans Pharma. Find a price of Metformin bulk offered by Marksans Pharma Indian Pharmaceutical Company who are into Pharmaceutical Drug Formulation manufacturing, Development and marketing of finished dosage. Oct 12, 2022 · Teva Pharma is a global leader in generic and specialty medicines with a portfolio of over 3,500 products, catering to over 200 million people daily. Applications of these drugs range from pain management, antibiotics, and cough and cold to antidiabetics, oncology, and digestives. Bells Healthcare specializes in delivering high-quality own-label products across Apr 20, 2023 · Teva Pharmaceutical Industries completed the sale of its manufacturing facility in Goa, India, to Marksans Pharma for an undisclosed price. The company also provides medicine that cure diseases such as epilepsy, skin infections, ulcers, gastrointestinal disorders, and more. Good evening, everyone. Nov 26, 2024 · Marksans Pharma hits new high; soars 30% in 1 month on healthy Q2 results The management anticipates stronger performance in the coming quarters due to the company's upcoming new launches, the onset of the winter season and scaling up of the TEVA facility. At Marksans, we leverage advanced research and development to formulate vitamin supplements that address specific health needs. khqmnbq hhs ygnrua dbpcx ojzoi xdbq albij kfh iwm qbvxo saeb kgo jei domwm ztkmz